BR112022014114A2 - Composições para gerenciar doença pulmonar obstrutiva crônica - Google Patents
Composições para gerenciar doença pulmonar obstrutiva crônicaInfo
- Publication number
- BR112022014114A2 BR112022014114A2 BR112022014114A BR112022014114A BR112022014114A2 BR 112022014114 A2 BR112022014114 A2 BR 112022014114A2 BR 112022014114 A BR112022014114 A BR 112022014114A BR 112022014114 A BR112022014114 A BR 112022014114A BR 112022014114 A2 BR112022014114 A2 BR 112022014114A2
- Authority
- BR
- Brazil
- Prior art keywords
- pulmonary disease
- chronic obstructive
- obstructive pulmonary
- compositions
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062962343P | 2020-01-17 | 2020-01-17 | |
| US202063126920P | 2020-12-17 | 2020-12-17 | |
| PCT/US2021/013763 WO2021146648A1 (en) | 2020-01-17 | 2021-01-16 | Compositions for managing chronic obstructive pulmonary disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112022014114A2 true BR112022014114A2 (pt) | 2022-09-13 |
Family
ID=76856592
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112022014114A BR112022014114A2 (pt) | 2020-01-17 | 2021-01-16 | Composições para gerenciar doença pulmonar obstrutiva crônica |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US11925606B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4090340B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7746272B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220128382A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115175672B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021207536B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022014114A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3164013A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021146648A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116847833A (zh) * | 2020-12-17 | 2023-10-03 | 萨米-萨宾莎集团有限公司 | 用于有效控制纤维母细胞样滑膜细胞介导的类风湿性关节炎的组合物 |
| WO2022203721A1 (en) * | 2021-03-25 | 2022-09-29 | Muhammed Majeed | Compositions and methods for inhibiting proteolytic activation of viruses |
| RS20220433A1 (sr) | 2022-05-11 | 2023-11-30 | Milan Prokin | Višeciljni antivirusni dodatak ishrani |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040266883A1 (en) * | 1999-10-27 | 2004-12-30 | Yale University | Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease |
| US20100179103A1 (en) * | 2008-07-21 | 2010-07-15 | Ketan Desai | Curcumin cyclodextrin combination for preventing or treating various diseases |
| US8486909B2 (en) * | 2009-06-24 | 2013-07-16 | Board Of Regents Of The University Of Nebraska | Compositions and methods for the diagnosis and treatment of inflammatory disorders and fibrotic disease |
| WO2011029931A1 (en) * | 2009-09-11 | 2011-03-17 | Protaffin Biotechnologie Ag | Composition for treatment of cxcl8-mediated lung inflammation |
| US20120077786A1 (en) * | 2010-09-27 | 2012-03-29 | Byron David A | Methods and compositions for disease treatment using inhalation |
| ITMI20132169A1 (it) * | 2013-12-20 | 2015-06-21 | Thompson S R L | Composizione per la prevenzione ed il trattamento della bpco e della sintomatologia correlata |
| EP3131636A4 (en) * | 2014-04-18 | 2018-01-10 | OmniActive Health Technologies Limited | Curcumin compositions and uses thereof |
| US20180036262A1 (en) * | 2015-03-10 | 2018-02-08 | The Research Foundation For The State University Of New York | Chemically modified curcumins for use in the production of lipoxins |
| JP6688009B2 (ja) * | 2015-04-15 | 2020-04-28 | 長谷川 浩二 | 酸化変性ｌｄｌ複合体抑制剤 |
| CN105998043B (zh) * | 2016-07-01 | 2018-11-27 | 吉林大学 | 槐属双苷在制备防治慢性阻塞性肺疾病药物中的应用 |
-
2021
- 2021-01-16 EP EP21741037.2A patent/EP4090340B1/en active Active
- 2021-01-16 CA CA3164013A patent/CA3164013A1/en active Pending
- 2021-01-16 BR BR112022014114A patent/BR112022014114A2/pt unknown
- 2021-01-16 KR KR1020227027330A patent/KR20220128382A/ko active Pending
- 2021-01-16 US US17/151,121 patent/US11925606B2/en active Active
- 2021-01-16 JP JP2022543653A patent/JP7746272B2/ja active Active
- 2021-01-16 CN CN202180015345.2A patent/CN115175672B/zh active Active
- 2021-01-16 AU AU2021207536A patent/AU2021207536B2/en active Active
- 2021-01-16 WO PCT/US2021/013763 patent/WO2021146648A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| KR20220128382A (ko) | 2022-09-20 |
| EP4090340B1 (en) | 2026-05-06 |
| CN115175672A (zh) | 2022-10-11 |
| NZ790708A (en) | 2025-05-02 |
| US20210220290A1 (en) | 2021-07-22 |
| CN115175672B (zh) | 2024-07-02 |
| EP4090340A4 (en) | 2024-02-21 |
| AU2021207536A1 (en) | 2022-08-11 |
| EP4090340A1 (en) | 2022-11-23 |
| WO2021146648A1 (en) | 2021-07-22 |
| AU2021207536B2 (en) | 2025-04-10 |
| JP7746272B2 (ja) | 2025-09-30 |
| JP2023512489A (ja) | 2023-03-27 |
| US11925606B2 (en) | 2024-03-12 |
| CA3164013A1 (en) | 2021-07-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR042578A1 (es) | Inhibidores de la sintesis de mucina | |
| MX2018000688A (es) | Triciclicos sustituidos y metodo para usarlos. | |
| HRP20130052T1 (hr) | Lijeäśenje respiratorne bolesti | |
| UA106098C2 (uk) | Аерозольна композиція для хозл | |
| WO2020217116A3 (en) | Long acting inhalation compositions of indacaterol | |
| JP2017527618A5 (cg-RX-API-DMAC7.html) | ||
| CL2020000597A1 (es) | Métodos y composiciones para tratar enfermedades pulmonares crónicas. | |
| WO2024086777A3 (en) | Compounds and methods for treating diseases caused by viruses and bacteria | |
| JP2023512489A5 (cg-RX-API-DMAC7.html) | ||
| BR112022020403A2 (pt) | Composições e métodos para tratar complicações de infecções virais e outros transtornos repiratórios | |
| ECSP24002381A (es) | Proteínas actrii y usos de las mismas | |
| CO2022005269A2 (es) | Composición de polvo seco inhalable contra enfermedades pulmonares | |
| Thompson | Neuroendocrine tumors of the larynx | |
| MX2024001207A (es) | Composiciones y metodos para el tratamiento de displasia broncopulmonar (bpd) y la hipertension pulmonar asociada a bpd. | |
| JP2023502259A5 (cg-RX-API-DMAC7.html) | ||
| JP2023520770A5 (cg-RX-API-DMAC7.html) | ||
| Liu et al. | Endobronchial solitary fibrous tumor: imaging and bronchoscopic findings | |
| Kim | Importance of alveolar recruitment strategy revisited | |
| NO20006665D0 (no) | Substituert ß-diketoner og deres anvendelse | |
| Mitre et al. | Correction to: Anesthesia for Intense Pulsed Light (IPL) Treatments | |
| Muhammed et al. | Assessment of pulmonary artery pressure in chronic obstructive pulmonary disease patients without resting hypoxemia | |
| WO2022221602A3 (en) | Compositions and methods for treating and/or preventing lung injury | |
| Dhavalshankh et al. | 2023e-17-nail _dystrophy_Heller | |
| Van Eeden et al. | D37 HELP: ADVANCES IN COPD THERAPEUTICS: Effect Of Statins On The Retention Of Ambient Particulate Matters (pm) In COPD | |
| Saha et al. | You Have Mucous Membrane Pemphigoid, Causing Subglottic Stenosis, and You Lived to Tell About It? |